Advertisement

The Scientist

» clinical trials and microbiology

Most Recent

image: Gutless Worm

Gutless Worm

By | July 1, 2015

Meet the digestive tract–lacking oligochaete that has fueled Max Planck researcher Nicole Dubilier’s interest in symbiosis and marine science.

0 Comments

image: Sold on Symbiosis

Sold on Symbiosis

By | July 1, 2015

A love of the ocean lured Nicole Dubilier into science; gutless sea worms and their nurturing bacterial symbionts keep her at the leading edge of marine microbiology.

0 Comments

image: Sponging Up Phosphorus

Sponging Up Phosphorus

By | July 1, 2015

Symbiotic bacteria in Caribbean reef sponges store polyphosphate granules, possibly explaining why phosphorous is so scarce in coral reef ecosystems.

1 Comment

image: The Sum of Our Parts

The Sum of Our Parts

By and | July 1, 2015

Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

14 Comments

image: Celladon Shutters Its R&D

Celladon Shutters Its R&D

By | June 26, 2015

Biotech firm likely to pull the plug after its gene therapy product fails.

0 Comments

image: Device Trials Go Unpublished

Device Trials Go Unpublished

By | June 24, 2015

Just half of the clinical studies used to gain premarket approval for cardiac devices ever make it into the scientific literature.

0 Comments

image: Ebola Drug Trial Terminated

Ebola Drug Trial Terminated

By | June 23, 2015

Early analysis of TKM-Ebola-Guinea offers discouraging results, causing sponsors to end the Phase 2 trial.

0 Comments

image: Drug for Low Sex Drive in Women?

Drug for Low Sex Drive in Women?

By | June 8, 2015

A federal advisory panel supports the US Food and Drug Administration’s approval of the first drug for female sexual dysfunction.

1 Comment

image: NIH Halts Drug Production

NIH Halts Drug Production

By | June 8, 2015

The National Institutes of Health’s Pharmaceutical Development Section temporarily suspends production following contamination issues.

0 Comments

image: NCI Gets Personal

NCI Gets Personal

By | June 2, 2015

The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.

0 Comments

Advertisement

Popular Now

  1. How Fats Influence the Microbiome
  2. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  3. Opinion: Engineering the Epigenome
  4. Psychology’s Failure to Replicate
Advertisement
Advertisement
Life Technologies